The collaboration with NCI was formed to interrogate the potential role of identification of host genomic abnormalities by FISH (Fluorescence in situ hybridization) as a screening tool for the detection of HPV-associated pre-cancerous cells and cancerous cells. NCI provided liquid biopsy specimens for analysis by FHACT™, CGI’s proprietary FISH-based HPV-Associated Cancer Test. The NCI also provided anal liquid biopsy specimens that will be used for the evaluation of FHACT™ in anal cancer.